IL2 and cancer: Comparisons with IL-2, IL-2 + anti-CD16 mAbs, IL-2 + anti-CD16 mAbs + sAJ2, IL-12, IL-15, IL-18, OSCSCs, and K562-expanded NK cells demonstrate the remarkable anti-cancer functions of sNK cells [61,64,65,66].